{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-043554","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2023-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.356574+00:00","generated_at":"2026-06-11T06:24:31.582027+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Renalytix's KidneyIntelX included in draft KDIGO 2023 chronic kidney disease guidelines","bullets":["Public comment period on draft KDIGO 2023 guidelines closed; final version expected Q4 2023.","KDIGO is a global nonprofit; guidelines are followed by clinicians worldwide.","Inclusion, if finalized, could drive broader adoption and reimbursement for KidneyIntelX in US and abroad.","Renalytix notes inclusion in draft does not guarantee inclusion in final guidelines."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-043554","json":"https://secwatch.observer/filing/0000950170-23-043554.json","markdown":"https://secwatch.observer/filing/0000950170-23-043554.md","text":"https://secwatch.observer/filing/0000950170-23-043554.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023043554/0000950170-23-043554-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023043554/rnlx-20230821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:24:31.582027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}